LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Author:
Funder
Eli Lilly and Company
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology
Reference54 articles.
1. Glucagon-like peptide 1 in health and disease;Andersen;Nature Reviews Endocrinology,2018
2. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model;Richards;Diabetes,2014
3. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut;Holst;FEBS Letters,1987
4. Glucagon-like peptide-1 7-36: a physiological incretin in man;Kreymann;Lancet,1987
5. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms;Imeryuz;American Journal of Physiology,1997
Cited by 485 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Peptide Drugs: Current Status and it's Applications in the Treatment of Various Diseases;Current Drug Research Reviews;2024-11
2. Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys;European Journal of Pharmaceutical Sciences;2024-11
3. Glucose-Dependent Insulinotropic Polypeptide Inhibits AGE-Induced NADPH Oxidase-Derived Oxidative Stress Generation and Foam Cell Formation in Macrophages Partly via AMPK Activation;International Journal of Molecular Sciences;2024-09-08
4. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07
5. Tirzepatide a novel anti diabetic molecule unfold dual action;Discover Public Health;2024-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3